Table of Contents Classification of Hydrocodone as a Schedule II Drug Updates On Changes in Hydrocodone Prescribing Practices Hydrocodone Addiction News Reports On Signs of Success References and Resources Classification of Hydrocodone as a Schedule II Drug In October 2014, The DEA changed hydrocodone combination analgesics from Schedule III of the Controlled Substances Act to…
Table of Contents FDA Approves Horizant Extended Release Tablets for the Treatment of Restless Legs Syndrome References and Resources FDA Approves Horizant Extended Release Tablets for the Treatment of Restless Legs Syndrome The FDA has approved a new drug, Horizant Extended-Release Tablets, for once a day use in treatment for moderate to severe cases of…
Table of Contents The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices References and Resources The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices The US Food and Drug Administration (FDA), and the Office of Prescription Drug Promotion (OPDP) sent a Warning Letter to Galt Pharmaceuticals LLC concerning its…
